Dermatology practical & conceptual最新文献

筛选
英文 中文
Acquired Perforating Dermatosis: Clinical and Histopathological Analysis of 95 Patients From One Center. 获得性穿孔性皮肤病:来自一个中心的 95 名患者的临床和组织病理学分析。
IF 2.8 4区 医学
Dermatology practical & conceptual Pub Date : 2024-04-01 DOI: 10.5826/dpc.1402a100
Yusuf Can Edek, Yağmur Aypek, Betül Öğüt, Özlem Erdem, Esra Adışen
{"title":"Acquired Perforating Dermatosis: Clinical and Histopathological Analysis of 95 Patients From One Center.","authors":"Yusuf Can Edek, Yağmur Aypek, Betül Öğüt, Özlem Erdem, Esra Adışen","doi":"10.5826/dpc.1402a100","DOIUrl":"10.5826/dpc.1402a100","url":null,"abstract":"<p><strong>Introduction: </strong>Acquired perforating dermatosis (APD) is a disease group characterized by transepidermal elimination of dermal connective tissue materials such as collagen, elastic fibers, and keratin through the epidermis and observed with pruritic skin lesions.</p><p><strong>Objectives: </strong>In this study, we aim to clarify the clinical, histopathological, and dermoscopic characteristics of APD, identify the associated systemic disease, and figure out treatment options.</p><p><strong>Methods: </strong>This study was designed as a single-center retrospective, observational, cross-sectional study. We evaluated all accessible APD cases between January 2004 and June 2022 in a tertiary care hospital.</p><p><strong>Results: </strong>A total of 95 patients with confirmed APD were included in the study. Sixty percent of the patients were women and 40% were men. The median age at diagnosis was 63.1 years (35-85 years). The most common site of lesions was the lower extremities which were detected in 86.31% of the patients. The concomitant systemic disease was identified in 84.21% of the patients. The most common systemic disease was type 2 diabetes mellitus (65.26%). Antihistamines and topical corticosteroids were the most commonly prescribed treatment agents.</p><p><strong>Conclusions: </strong>Transepidermal elimination of dermal connective tissue components is a feature of APD and the disease usually presents with pruritic papules and nodules with central keratotic crust or plug. The diagnosis of APD requires a clinical examination and histological investigation. APD is usually accompanied by systemic comorbidities. There are several topical and systemic medications available for APD, however, sometimes the therapy might be challenging.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11135951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141175300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bullous Kaposi Sarcoma: An Uncommon Blistering Variant in an HIV-Negative Patient. 大疱性卡波西肉瘤:一名 HIV 阴性患者身上的罕见大疱变异。
IF 2.8 4区 医学
Dermatology practical & conceptual Pub Date : 2024-04-01 DOI: 10.5826/dpc.1402a113
Eleonora Gherardi, Luca Tinunin, Tommaso Grassi, Vincenza Maio, Vieri Grandi
{"title":"Bullous Kaposi Sarcoma: An Uncommon Blistering Variant in an HIV-Negative Patient.","authors":"Eleonora Gherardi, Luca Tinunin, Tommaso Grassi, Vincenza Maio, Vieri Grandi","doi":"10.5826/dpc.1402a113","DOIUrl":"10.5826/dpc.1402a113","url":null,"abstract":"","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11135947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141175346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nilotinib Induced Keratosis Pilaris in a Female with Chronic Myeloid Leukemia. 尼罗替尼诱发慢性髓性白血病女性患者皮肤角化症。
IF 2.8 4区 医学
Dermatology practical & conceptual Pub Date : 2024-04-01 DOI: 10.5826/dpc.1402a82
Ranjana Beniwal, Akriti Agrawal
{"title":"Nilotinib Induced Keratosis Pilaris in a Female with Chronic Myeloid Leukemia.","authors":"Ranjana Beniwal, Akriti Agrawal","doi":"10.5826/dpc.1402a82","DOIUrl":"10.5826/dpc.1402a82","url":null,"abstract":"","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11135930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety. 在希腊人群中使用托法替尼和巴利昔尼治疗斑秃的真实世界经验:以安全性为重点的回顾性分析。
IF 2.8 4区 医学
Dermatology practical & conceptual Pub Date : 2024-04-01 DOI: 10.5826/dpc.1402a73
Zoe Apalla, Efterpi Zafiriou, Effimia Zagkliverinou, Angeliki-Viktoria Roussaki-Schulze, Polyxeni Gidarokosta, Niki Ntavari, Stella Sakellaropoulou, Maria Boziou, Anastasia Emvalomati, Eirini Kyrmanidou, Elizabeth Lazaridou
{"title":"Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety.","authors":"Zoe Apalla, Efterpi Zafiriou, Effimia Zagkliverinou, Angeliki-Viktoria Roussaki-Schulze, Polyxeni Gidarokosta, Niki Ntavari, Stella Sakellaropoulou, Maria Boziou, Anastasia Emvalomati, Eirini Kyrmanidou, Elizabeth Lazaridou","doi":"10.5826/dpc.1402a73","DOIUrl":"10.5826/dpc.1402a73","url":null,"abstract":"<p><strong>Introduction: </strong>The introduction of Janus Kinase inhibitors (JAKi) seems to revolutionize the field of alopecia areata (AA) therapeutics. However, real-world data are still missing.</p><p><strong>Objectives: </strong>To provide evidence about effectiveness and safety of tofacitinib and baricitinib in AA in real-world settings and describe baseline disease characteristics and patients profiles that are considered good candidates for JAKi in the daily practice. Furthermore, we intended to investigate potential correlations between baseline characteristics and treatment outcomes.</p><p><strong>Methods: </strong>We retrospectively reviewed the databases of two tertiary Hospitals in Greece, to identify individuals of any age currently being treated with systemic JAKi for severe AA.</p><p><strong>Results: </strong>We identified 42 individuals, including 3 adolescents. In our cohort, 52.3% (22/42) were under tofacitinib and 47.6% (20/42) under baricitinib treatment. Efficacy analysis was performed on the subgroup of 30 patients that had completed at least a 3-month follow-up on treatment. In the latter group, mean time on treatment was 10 months. Mean Severity of Alopecia Tool and mean Dermatology Life Quality Index scores decreased from 84.46% and 12.86 at baseline, to 43.26% and 6.63, respectively. Complete response (CR) was recorded in 4 (13.33%), partial in 12 (40%) and no response in 14 patients (46.66%), correspondingly. Seventeen out of 42 (40.5%) individuals in total, reported at least 1 adverse event. No patient required hospitalization. Among 15 patients (35.7%) who got COVID-19, one suffered from serious infection. The 3 adolescents achieved CR with no significant adverse events.</p><p><strong>Conclusions: </strong>Real-world data suggest efficacy and safety of JAKi in severe forms of AA. Tolerability is optimal in younger individuals.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11136076/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
There Exist Educational Deficiencies in Specialized Dermatologic Care: Implications for Patients of Different Sexes, Genders, and Sexual Orientations. 皮肤病专科护理中存在教育缺陷:对不同性别和性取向患者的影响。
IF 2.8 4区 医学
Dermatology practical & conceptual Pub Date : 2024-04-01 DOI: 10.5826/dpc.1402a128
Isabella Mark, Michael J Diaz, Jasmine T Tran, Shari R Lipner
{"title":"There Exist Educational Deficiencies in Specialized Dermatologic Care: Implications for Patients of Different Sexes, Genders, and Sexual Orientations.","authors":"Isabella Mark, Michael J Diaz, Jasmine T Tran, Shari R Lipner","doi":"10.5826/dpc.1402a128","DOIUrl":"10.5826/dpc.1402a128","url":null,"abstract":"","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11135945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermoscopic Findings in Skin Infection by Mycobacterium Immunogenum. 免疫分枝杆菌皮肤感染的皮肤镜检查结果
IF 2.8 4区 医学
Dermatology practical & conceptual Pub Date : 2024-04-01 DOI: 10.5826/dpc.1402a115
José Magna Aguirre, Paula Almeida Abarcia, Pablo Vargas Mora
{"title":"Dermoscopic Findings in Skin Infection by Mycobacterium Immunogenum.","authors":"José Magna Aguirre, Paula Almeida Abarcia, Pablo Vargas Mora","doi":"10.5826/dpc.1402a115","DOIUrl":"10.5826/dpc.1402a115","url":null,"abstract":"","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11136040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141175411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermoscopy of Thick Scalp Melanoma: Is It Always an Easy Diagnosis? 厚头皮黑色素瘤的皮肤镜检查:诊断一定很容易吗?
IF 2.8 4区 医学
Dermatology practical & conceptual Pub Date : 2024-04-01 DOI: 10.5826/dpc.1402a143
Sebastiano Pellerone, Chiara Pensa, Giustino Riccio, Gabriella Brancaccio, Giuseppe Argenziano, Elvira Moscarella
{"title":"Dermoscopy of Thick Scalp Melanoma: Is It Always an Easy Diagnosis?","authors":"Sebastiano Pellerone, Chiara Pensa, Giustino Riccio, Gabriella Brancaccio, Giuseppe Argenziano, Elvira Moscarella","doi":"10.5826/dpc.1402a143","DOIUrl":"10.5826/dpc.1402a143","url":null,"abstract":"","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11135920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141175434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of the C-Reactive Protein to Albumin Ratio in the Diagnosis and Prognosis of Mycosis Fungoides. C反应蛋白与白蛋白比值在真菌病诊断和预后中的重要性
IF 2.8 4区 医学
Dermatology practical & conceptual Pub Date : 2024-04-01 DOI: 10.5826/dpc.1402a97
Gamze Taş-Aygar, Hatice Ataş, Müzeyyen Gönül, Selda Pelin Kartal
{"title":"Importance of the C-Reactive Protein to Albumin Ratio in the Diagnosis and Prognosis of Mycosis Fungoides.","authors":"Gamze Taş-Aygar, Hatice Ataş, Müzeyyen Gönül, Selda Pelin Kartal","doi":"10.5826/dpc.1402a97","DOIUrl":"10.5826/dpc.1402a97","url":null,"abstract":"<p><strong>Introduction: </strong>The C-reactive protein to albumin ratio (CAR) lately has demonstrated as a prognostic factor and an indicator of disease activity, severity and prognosis in solid organ malignancies and inflammatory diseases. However, the effects of CAR have not been investigated in mycosis fungoides (MF) patients yet.</p><p><strong>Objectives: </strong>This study aimed to determine the potential role of CAR as a diagnostic and a prognostic indicator in MF.</p><p><strong>Methods: </strong>We retrospectively investigated the electronic medical records of 97 patients with MF admitted to the Dermatology Clinic of Health Sciences University, Diskapi Yildirim Beyazit Training and Research Hospital between January 2014 and December 2020. In total, 60 patients with MF were enrolled in the study. CAR was evaluated, patient and control group. Also, the other clinicopathological factors including age, lactate dehydrogenase, stage of disease, beta-2-microglobulin levels, and sedimentation levels were evaluated.</p><p><strong>Results: </strong>The median value of CAR was 0.85 (0.10-7.51) in the patient group, whereas it was 0.39 (0.0-1.11) in the control group (P < 0.001). Patients with disease progression (N = 16, 13M, 3 F) had a median value of CAR 0.84 (0.10-7.51) and the median value of CAR (N = 44) was 0.86 (0.12-4.57) in the group of patients with stable disease. The CAR value had no prognostic significance (P > 0.05).</p><p><strong>Conclusions: </strong>There is no association between the CAR and progression in the stage in MF patients. But the CAR is significantly higher in patients with MF than in the control group. The CAR can be a guide for us in cases where we have difficulty in diagnosing.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11135996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intralesional Quadrivalent Human Papilloma Virus Vaccine Versus Candida Antigen in the Treatment of Multiple Recalcitrant Non-Genital Warts. 治疗多发性顽固性非生殖器疣的四价人乳头瘤病毒疫苗与念珠菌抗原的椎管内注射。
IF 2.8 4区 医学
Dermatology practical & conceptual Pub Date : 2024-04-01 DOI: 10.5826/dpc.1402a66
Ibrahim Fouda, Hassan Abou Khodair Mohammed, Ghada Mohammed Yousef Mohammed
{"title":"Intralesional Quadrivalent Human Papilloma Virus Vaccine Versus Candida Antigen in the Treatment of Multiple Recalcitrant Non-Genital Warts.","authors":"Ibrahim Fouda, Hassan Abou Khodair Mohammed, Ghada Mohammed Yousef Mohammed","doi":"10.5826/dpc.1402a66","DOIUrl":"10.5826/dpc.1402a66","url":null,"abstract":"<p><strong>Introduction: </strong>Warts are the most prevalent clinical manifestation of Human Papilloma Virus (HPV) infections, which vary in morphological pattern depending on the site of the body affected.</p><p><strong>Objectives: </strong>To evaluate the safety and efficacy of intralesional quadrivalent HPV vaccine versus candida antigen in treatment of multiple recalcitrant non-genital warts.</p><p><strong>Methods: </strong>A randomized-control clinical trial included 60 cases with multiple recalcitrant warts who were randomly distributed into three groups; Group I included 20 patients who received intralesional candida antigen at a dose of 0.3 mL of 1/1000 solution, Group II included 20 patients who received intralesional quadrivalent HPV vaccine at a dose of 0.3ml and Group III included 20 patients who received intralesional injection 0.3 ml of normal saline 0.9% as a control group). Each agent was injected at the base of the largest wart every three weeks until it was completely cleared, or for a total of four sessions.</p><p><strong>Results: </strong>the highest response rate was detected in the quadrivalent HPV vaccine group (75% complete response) followed by the candida vaccine group (40% complete response and 15% partial response). Also, regarding the distant response rate, the highest response rate was detected in the quadrivalent HPV vaccine group (72.7% complete response and 27.3% partial response) followed by the candida vaccine group (33.3% complete response and 50% partial response).</p><p><strong>Conclusions: </strong>Intralesional immunotherapy appears to be effective and safe in treating multiple recalcitrant non-genital warts, with intralesional quadrivalent HPV vaccine outperforming intralesional candida antigen.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11135915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Porokeratosis Ptychotropica Mimicking Anogenital Warts. 模仿外生殖器疣的角化病(Porokeratosis Ptychotropica)。
IF 2.8 4区 医学
Dermatology practical & conceptual Pub Date : 2024-04-01 DOI: 10.5826/dpc.1402a111
Tugba Kevser Uzuncakmak, Necmettin Akdeniz, Pembe Gül Güneş
{"title":"Porokeratosis Ptychotropica Mimicking Anogenital Warts.","authors":"Tugba Kevser Uzuncakmak, Necmettin Akdeniz, Pembe Gül Güneş","doi":"10.5826/dpc.1402a111","DOIUrl":"10.5826/dpc.1402a111","url":null,"abstract":"","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11135953/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信